Tachyplesin I
Internal ID | ddab8da5-49c2-48e7-94ac-dc13ea354e07 |
Taxonomy | Organic Polymers > Polypeptides |
IUPAC Name | (1R,4S,7S,10S,13R,18R,21S,24S,27S,30R,33S,39S,42S)-N-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-10-benzyl-33-[(2S)-butan-2-yl]-7,21,24,39-tetrakis(3-carbamimidamidopropyl)-13-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-27,42-bis[(4-hydroxyphenyl)methyl]-3,6,9,12,20,23,26,29,32,35,38,41,44-tridecaoxo-4-propan-2-yl-15,16,46,47-tetrathia-2,5,8,11,19,22,25,28,31,34,37,40,43-tridecazabicyclo[28.14.4]octatetracontane-18-carboxamide |
SMILES (Canonical) | CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CC4=CC=C(C=C4)O)CCCNC(=N)N)CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCCN)N)CC7=CC=CC=C7)CCCNC(=N)N)C(C)C |
SMILES (Isomeric) | CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CC4=CC=C(C=C4)O)CCCNC(=N)N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCCN)N)CC7=CC=CC=C7)CCCNC(=N)N)C(C)C |
InChI | InChI=1S/C99H151N35O19S4/c1-5-53(4)78-94(153)132-75-51-157-156-50-74(91(150)127-69(43-55-28-32-58(135)33-29-55)85(144)121-64(24-14-38-114-96(105)106)81(140)119-47-76(137)133-78)131-93(152)77(52(2)3)134-84(143)67(27-17-41-117-99(111)112)124-86(145)68(42-54-18-7-6-8-19-54)126-90(149)73(130-88(147)71(125-80(139)61(101)21-11-12-36-100)45-57-46-118-62-22-10-9-20-60(57)62)49-155-154-48-72(89(148)120-63(79(102)138)23-13-37-113-95(103)104)129-83(142)66(26-16-40-116-98(109)110)122-82(141)65(25-15-39-115-97(107)108)123-87(146)70(128-92(75)151)44-56-30-34-59(136)35-31-56/h6-10,18-20,22,28-35,46,52-53,61,63-75,77-78,118,135-136H,5,11-17,21,23-27,36-45,47-51,100-101H2,1-4H3,(H2,102,138)(H,119,140)(H,120,148)(H,121,144)(H,122,141)(H,123,146)(H,124,145)(H,125,139)(H,126,149)(H,127,150)(H,128,151)(H,129,142)(H,130,147)(H,131,152)(H,132,153)(H,133,137)(H,134,143)(H4,103,104,113)(H4,105,106,114)(H4,107,108,115)(H4,109,110,116)(H4,111,112,117)/t53-,61-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,77-,78-/m0/s1 |
InChI Key | ZJQFYZCNRTZAIM-PMXBASNASA-N |
Popularity | 137 references in papers |
Molecular Formula | C99H151N35O19S4 |
Molecular Weight | 2263.80 g/mol |
Exact Mass | 2263.0841873 g/mol |
Topological Polar Surface Area (TPSA) | 1030.00 Ų |
XlogP | -2.70 |
Atomic LogP (AlogP) | -6.01 |
H-Bond Acceptor | 30 |
H-Bond Donor | 37 |
Rotatable Bonds | 42 |
Tachyplesin |
118231-04-2 |
KWCFRVCYRGICYRRCR-NH2 |
tachyplesin peptide, Tachypleus tridentatus |
CHEMBL4544197 |
HY-P1632 |
Tachyplesin I (Tachypleus tridentatus) |
CS-0065054 |
Tachyplesin I (reduced), cyclic (3.16),(7.12)-bis(disulfide) |
NH2-Lys-Trp-Cys(x2)-Phe-Arg-Val-Cys(x1)-Tyr-Arg-Gly-Ile-Cys(x1)-Tyr-Arg-Arg-Cys(x2)-Arg-NH2 |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9676 | 96.76% |
Caco-2 | - | 0.8588 | 85.88% |
Blood Brain Barrier | - | 0.7500 | 75.00% |
Human oral bioavailability | - | 0.6286 | 62.86% |
Subcellular localzation | Mitochondria | 0.6248 | 62.48% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.8321 | 83.21% |
OATP1B3 inhibitior | + | 0.9388 | 93.88% |
MATE1 inhibitior | - | 0.5844 | 58.44% |
OCT2 inhibitior | - | 0.6250 | 62.50% |
BSEP inhibitior | + | 0.9686 | 96.86% |
P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
P-glycoprotein substrate | + | 0.8882 | 88.82% |
CYP3A4 substrate | + | 0.7537 | 75.37% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.8049 | 80.49% |
CYP3A4 inhibition | + | 0.5000 | 50.00% |
CYP2C9 inhibition | - | 0.7024 | 70.24% |
CYP2C19 inhibition | - | 0.6614 | 66.14% |
CYP2D6 inhibition | - | 0.8589 | 85.89% |
CYP1A2 inhibition | - | 0.8131 | 81.31% |
CYP2C8 inhibition | + | 0.7740 | 77.40% |
CYP inhibitory promiscuity | - | 0.8239 | 82.39% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.7600 | 76.00% |
Carcinogenicity (trinary) | Non-required | 0.5656 | 56.56% |
Eye corrosion | - | 0.9815 | 98.15% |
Eye irritation | - | 0.8952 | 89.52% |
Skin irritation | - | 0.7652 | 76.52% |
Skin corrosion | - | 0.9177 | 91.77% |
Ames mutagenesis | - | 0.6754 | 67.54% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.7242 | 72.42% |
Micronuclear | + | 0.7700 | 77.00% |
Hepatotoxicity | - | 0.6125 | 61.25% |
skin sensitisation | - | 0.8390 | 83.90% |
Respiratory toxicity | + | 0.8667 | 86.67% |
Reproductive toxicity | + | 0.9000 | 90.00% |
Mitochondrial toxicity | + | 0.7625 | 76.25% |
Nephrotoxicity | - | 0.7624 | 76.24% |
Acute Oral Toxicity (c) | III | 0.5676 | 56.76% |
Estrogen receptor binding | - | 0.6246 | 62.46% |
Androgen receptor binding | + | 0.7531 | 75.31% |
Thyroid receptor binding | + | 0.8328 | 83.28% |
Glucocorticoid receptor binding | + | 0.8631 | 86.31% |
Aromatase binding | + | 0.8316 | 83.16% |
PPAR gamma | + | 0.7914 | 79.14% |
Honey bee toxicity | - | 0.6194 | 61.94% |
Biodegradation | - | 0.8500 | 85.00% |
Crustacea aquatic toxicity | + | 0.5700 | 57.00% |
Fish aquatic toxicity | + | 0.9454 | 94.54% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 99.96% | 93.10% |
CHEMBL2581 | P07339 | Cathepsin D | 99.85% | 98.95% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.71% | 96.09% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.70% | 83.82% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.64% | 91.11% |
CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 99.54% | 91.71% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.44% | 97.23% |
CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.06% | 97.64% |
CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 98.12% | 91.81% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 98.09% | 90.08% |
CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 98.01% | 88.10% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.91% | 94.45% |
CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 97.90% | 96.67% |
CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 97.79% | 85.00% |
CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 97.77% | 88.56% |
CHEMBL3837 | P07711 | Cathepsin L | 97.52% | 96.61% |
CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 97.08% | 90.24% |
CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 96.96% | 96.11% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 96.39% | 95.50% |
CHEMBL2535 | P11166 | Glucose transporter | 96.37% | 98.75% |
CHEMBL1255126 | O15151 | Protein Mdm4 | 96.31% | 90.20% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 95.70% | 96.90% |
CHEMBL236 | P41143 | Delta opioid receptor | 95.60% | 99.35% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 95.47% | 97.14% |
CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.19% | 100.00% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 95.16% | 94.75% |
CHEMBL4071 | P08311 | Cathepsin G | 95.12% | 94.64% |
CHEMBL1801 | P00747 | Plasminogen | 94.79% | 92.44% |
CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 94.68% | 92.32% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 94.59% | 98.05% |
CHEMBL2821 | P00748 | Coagulation factor XII | 93.79% | 96.21% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 93.79% | 95.56% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.53% | 97.09% |
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 93.26% | 82.86% |
CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 92.84% | 95.00% |
CHEMBL233 | P35372 | Mu opioid receptor | 92.21% | 97.93% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 92.00% | 98.33% |
CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 91.95% | 99.09% |
CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 91.84% | 100.00% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 91.74% | 99.17% |
CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 91.60% | 96.33% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 91.59% | 95.50% |
CHEMBL1980 | Q14524 | Sodium channel protein type V alpha subunit | 91.20% | 92.50% |
CHEMBL255 | P29275 | Adenosine A2b receptor | 90.61% | 98.59% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 90.30% | 90.17% |
CHEMBL1914 | P06276 | Butyrylcholinesterase | 89.76% | 95.00% |
CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 89.52% | 96.28% |
CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 89.41% | 94.62% |
CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 89.05% | 83.10% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.07% | 100.00% |
CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 87.58% | 98.94% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 86.82% | 95.89% |
CHEMBL4633 | P22001 | Voltage-gated potassium channel subunit Kv1.3 | 85.87% | 100.00% |
CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 85.67% | 100.00% |
CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 85.64% | 97.29% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.50% | 95.89% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 85.14% | 96.47% |
CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 85.08% | 96.69% |
CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 84.72% | 96.67% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 83.96% | 82.69% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 83.60% | 99.23% |
CHEMBL220 | P22303 | Acetylcholinesterase | 83.01% | 94.45% |
CHEMBL3038469 | P24941 | CDK2/Cyclin A | 82.95% | 91.38% |
CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 82.89% | 95.83% |
CHEMBL2431 | P31751 | Serine/threonine-protein kinase AKT2 | 82.23% | 98.33% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 82.22% | 91.19% |
CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 82.12% | 96.25% |
CHEMBL4461 | Q9NTG7 | NAD-dependent deacetylase sirtuin 3 | 82.02% | 94.36% |
CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 81.81% | 89.67% |
CHEMBL3891 | P07384 | Calpain 1 | 81.41% | 93.04% |
CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 81.19% | 89.33% |
CHEMBL3176 | O43603 | Galanin receptor 2 | 81.14% | 98.89% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 80.44% | 93.00% |
CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 80.10% | 98.24% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 80.00% | 93.56% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
There are no matching plants. |
PubChem | 16129721 |
LOTUS | LTS0056209 |
wikiData | Q104389490 |